Breast cancer is a profoundly personal disease, and blanket approaches may not work for all patients. In fact, some can avoid particular therapies or treatments altogether. BCRF investigators have played a significant role in developing precision medicine and individualized therapies, improving treatment efficacy and limiting side effects.

This is the area where Dr. Roisin Connolly’s work is centered. In this latest episode Dr. Connolly discusses her work to uncover more personalized treatments for breast cancer patients with triple-negative breast cancer. A BCRF investigator since 2022, Dr. Connolly is the Director and Professor Gerald O’Sullivan Chair in cancer research at University of College Cork and Cork University Hospital in Ireland.